Radiation pneumonitis after definitive concurrent chemoradiotherapy with cisplatin/docetaxel for non‐small cell lung cancer: Analysis of dose‐volume parameters
Kuniaki Katsui(Fukuyama City Hospital), Susumu Kanazawa(Okayama University), Shinichi Toyooka(Okayama University Hospital), Yoshinobu Maeda(Okayama University Hospital), Takao Hiraki(Okayama University), Katsuyuki Kiura(Okayama University Hospital), Norihisa Katayama(Okayama University), Takeshi Ogata(Iwakuni Medical Center), Masahiro Kuroda(Okayama University), Kenta Watanabe(Okayama University)
Cited by 22
Related Papers
Accurate diagnosis of musculoskeletal lesions by core needle biopsy
|Journal of Surgical Oncology|2006|162
Non–Small Cell Lung Cancer Cells Acquire Resistance to the ALK Inhibitor Alectinib by Activating Alternative Receptor Tyrosine Kinases
|Cancer Research|2016|128
Liposomal Delivery of MicroRNA-7–Expressing Plasmid Overcomes Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Resistance in Lung Cancer Cells
|Molecular Cancer Therapeutics|2011|126
Pretreatment prognostic nutritional index is a significant predictor of prognosis in patients with cervical cancer treated with concurrent chemoradiotherapy
|Molecular and Clinical Oncology|2016|79